BridgeMD
New treatment option for Alzheimer Disease
Official title New Imaging Biomarkers Predictive of MA Progression
ClinicalTrials.gov ID: NCT05939362
What this study is testing
- What it's testing
- The pathophysiology of AD is complex. In addition to amyloid plaques and neurofibrillary degeneration, there is a metabolic alteration of the energy pathways, oxidative phosphorylation and glycolysis, which are involved in brain function.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 60 to 90
You may be able to join if
- French-speaking patients aged 60 to 90 years,
- Patient in the context of Alzheimer's disease \ for which imaging after MRI is prescribed as part of the usual diagnostic process, \ Alzheimer's...
- MMSE score ≥18,
- Written informed consent after the patient has been informed,
- Progressive decline for at least 6 months.
You likely can't join if
- --Partially or completely illiterate patient unable to read and write,
- Patient with an absolute contraindication to 7T MRI
- Severe psychiatric pathology not balanced,
- Non-degenerative neurological disease (stroke, multiple sclerosis ...),
- Patient with tumor or inflammatory pathology, or vascular leukopathy visualized in MRI (Fazekas score \> 3)
The study team makes the final eligibility decision.
Where it's taking place
- Poitiers, France
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 60 years to 90 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Poitiers, France. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.